Community Based Trial for AMEVIVE®

Clinical trial NCT00168753 · COMPLETED

Trial details

NCT number: NCT00168753
Sponsor: Astellas Pharma Inc
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Moderate to Severe Chronic Plaque Psoriasis

Start date: 2004-07-01
Primary completion: 2005-03-01
Enrollment: 114

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.